Advanced Search

Journal of Traditional Chinese Medicine >

2022 , Vol. 42 >Issue 3: 479 - 486

DOI: https://doi.org/10.19852/j.cnki.jtcm.20220408.003

Review

Integration strategy of network pharmacology in Traditional Chinese Medicine: a narrative review

  • Jiashuo WU ,
  • Fangqing ZHANG ,
  • Zhuangzhuang LI ,
  • Weiyi JIN ,
  • Yue SHI
Expand
  • 1 Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China
    2 Hebei Medical University, Shijiazhuang 050017, China
SHI Yue, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China. shiyue1029@126.com,Telephone: +86-10-57833270; +86-10-57833255

Received date: 2021-07-16

  Accepted date: 2021-10-14

  Online published: 2022-04-08

Fold

Abstract

Traditional Chinese Medicine (TCM) has been extensively used as a mainstay for treating various pathologies. Combing the pharmacology and systems biology approaches, the network pharmacology (NP) approach was developed to predict the probable mechanism underlying the therapeutic effect of TCM. However, approaches solely based on NP cannot effectively elucidate the curative mechanism in a holistic and reliable manner due to limitations in NP-based methods and complexity of TCM components. Thus, integration strategies combining NP with other approaches are increasingly being used. Since the interdisciplinary research in TCM has received much attention in the advent of the big data era of which the NP-based integration strategy is broadly used, the strategy is clearly elaborated in the present review. We summarized several NP-based integration strategies and their applications in TCM studies, including multi-omics approach, gut microbiota study, chemical information analysis, data-mining, and network toxicology study.

Key words： network pharmacology; toxicology; medicine; Chinese traditional; integration strategy; review

Cite this article

Jiashuo WU , Fangqing ZHANG , Zhuangzhuang LI , Weiyi JIN , Yue SHI . Integration strategy of network pharmacology in Traditional Chinese Medicine: a narrative review[J]. Journal of Traditional Chinese Medicine, 2022 , 42(3) : 479 -486 . DOI: 10.19852/j.cnki.jtcm.20220408.003

References

1 Lin HS, Jie L, Zhang Y. Developments in cancer prevention and treatment using Traditional Chinese Medicine. Front Med 2011; 5:127-33.
2 Fan H, Lu F, Yang A, et al. A review on the nonpharmacological therapy of Traditional Chinese Medicine with antihypertensive effects. Evid-based Complement Altern Med 2019; 2019:1-7.
3 Barnes MA, Barbara M. Complementary and alternative medicine use among adults: United States. National health statistics reports 2008; 12:1-23.
4 Andrew L Hopkins. Network pharmacology. Nat Biotechnol 2007; 25:1110-11.
5 Li S. Network systems underlying Traditional Chinese Medicine syndrome and herb formula. Curr Bioinform 2009; 4:110-20.
6 Li S. Network target for screening synergistic drug combinations with application to Traditional Chinese Medicine. BMC Syst Biol 2011; 5:188-96.
7 Li S, Zhang B. Traditional Chinese Medicine network pharmacology: theory, methodology and application. Chin J Nat Med 2013; 11:110-20.
8 Wang YH, Yang L. Systems pharmacology-based research framework of Traditional Chinese Medicine. Shi Jie Zhong Yi Yao 2013; 7:103-10.
9 Li X, Xu X, Wang J, et al. A system-level investigation into the mechanisms of Chinese traditional medicine: compound Danshen formula for cardiovascular disease treatment. PLoS One 2012; 7:e43918.
10 Tao W, Xu X, Wang J, et al. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. J Ethnopharmacol 2013; 145:1-10.
11 Xu HY, Yan, HJ. Integrative pharmacology: new paradigm of modernization of Chinese medicine. Zhong Guo Zhong Yao Za Zhi 2014; 39:357-62.
12 Huang T, Zhong LLD, Lin CY, et al. Approaches in studying the pharmacology of Chinese Medicine formulas: bottom-up, top-down-and meeting in the middle. Chin Med 2018; 13:15.
13 Park SY, Park JH, Kim HS, et al. Systems-level mechanisms of action of Panax ginseng: a network pharmacological approach. Ginseng Res 2018; 42:98-106.
14 Sun D, Yan Q, Xu X, et al. LC-MS/MS analysis and evaluation of the anti-inflammatory activity of components from Bushen Huoxue decoction. Pharm Biol 2017; 55:937-45.
15 Xiang L, Fan Y, Hang F, et al. Intraconversion of Polar Ginsenosides, their transformation into less-polar ginsenosides, and Ginsenoside acetylation in Ginseng flowers upon baking and steaming. Molecules 2018; 23:759.
16 Stumpf WE. The dose makes the medicine. Drug Discov Today 2006; 11:550-55.
17 Ru JL, Li P, Wang JN, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminformatics 2014; 6:13.
18 Chen WB, Zhuang J, Gong L, et al. Investigating the dysfunctional pathogenesis of Wilms’ tumor through a multidimensional integration strategy. J Transl Med 2019; 9:266-73.
19 Pan L, Zhang J, Wang J, et al. ITRAQ-based quantitative proteomic analysis reveals proteomic changes in three fenoxaprop-P-ethyl-resistant Beckmannia syzigachne biotypes with differing ACCase mutations. J Proteomics 2017; 160:47-54.
20 Zhu HG, Cheng WH, Tian WG, et al. iTRAQ-based comparative proteomic analysis provides insights into somatic embryogenesis in Gossypium hirsutum L. Plant Mol Biol 2018; 96:89-102.
21 Zhao J, Xie M, Liu JN, et al. Investigation of the therapy targets of Yi-Qi-Yang-Yin-Hua-Tan-Qu-Yu recipe on type 2 diabetes by serum proteome labeled with iTRAQ. J Ethnopharmacol 2018; 224:1-14.
22 Liu CN, Chen J, Yang S, et al. The Chinese herbal formula Zhibai Dihuang Granule treat Yin-deficiency-heat syndrome rats by regulating the immune responses. J Ethnopharmacol 2018; 225:271-78.
23 Liu XJ, Shi Y, Hu YH, et al. Bupleurum marginatum Wall. ex DC in liver fibrosis: pharmacological evaluation, differential prote-omics, and network pharmacology. Front Pharmacol 2018; 9:524.
24 Zhao P, Li J, Yang L, et al. Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease. Mol Med Rep 2018; 17:5247-57.
25 Lima-Leite A, Gualiume Vaz Madureira Lobo J, Barbosa da Silva Pereira, et al. Proteomic analysis of gastrocnemius muscle in rats with streptozotocin-induced diabetes and chronically exposed to fluoride. PloS one 2014; 9:e106646.
26 Wang Z, Linghu KG, Hu Y, et al. Deciphering the pharmacological mechanisms of the Huayu-Qiangshen-Tongbi formula through integrating network pharmacology and in vitro pharmacological investigation. Front Pharmacol 2019; 10:1065.
27 Misra BB, Mohapatra S. Tools and resources for metabolomics research community: a 2017-2018 update. Electrophoresis 2019; 40, 227-246.
28 Luo H, Sun SJ, Wang Y, et al. Revealing the sedative-hypnotic effect of the extracts of herb pair Semen Ziziphi spinosae and Radix Polygalae and related mechanisms through experiments and metabolomics approach. BMC Complement Med Ther 2020; 20, 206.
29 Wang XM, Xu WJ, Xu LK, et al. Antipyretic effect of herba Ephedrae-Ramulus Cinnamomi herb pair on yeast-induced pyrexia rats: a metabolomics study. Chin J Integr Med 2018; 24:676-82.
30 Wang D, Li R, Wei S, et al. Metabolomics combined with network pharmacology exploration reveals the modulatory properties of Astragali Radix extract in the treatment of liver fibrosis. Chin Med 2019; 14:30.
31 Hua YL, Ma Q, Yuan ZW, et al. A novel approach based on metabolomics coupled with network pharmacology to explain the effect mechanisms of Danggui Buxue Tang in anaemia. Chin J Nat Med 2019; 17:275-90.
32 Wang Z, Liang H, Cao H, et al. Efficient ligand discovery from natural herbs by integrating virtual screening, affinity mass spectrometry and targeted metabolomics. Analyst 2019; 144:2881-90.
33 Bai JP, Abernethy DR. Systems pharmacology to predict drug toxicity: integration across levels of biological organization. Annu Rev Pharmacol Toxicol 2013; 53:451-73.
34 Li XY, Jin X, Li YZ, et al. Network toxicology and LC-MS-based metabolomics: new approaches for mechanism of action of toxic components in traditional Chinese medicines. Chin Herb Med 2019; 11:357-63.
35 Zhang W, Chen Y, Jiang H, et al. Integrated strategy for accurately screening biomarkers based on metabolomics coupled with network pharmacology. Talanta 2020; 211:120710.
36 Sultan M, Schulz MH, Richard H, et al. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 2008; 321:956-60.
37 Banchereau R, Cepika AM, Banchereau J, et al. Understanding human autoimmunity and autoinflammation through transcriptomics. Annu Rev Immunol 2017; 35:337-70.
38 Wang Z, Gerstei M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009; 10:57-63.
39 Yang Q, Gao L, Tao M, et al. Transcriptomics analysis of Candida albicans treated with Huanglian Jiedu decoction using RNA-seq. Evid Based Complement Alternat Med 2016; 2016, 3198249.
40 Chen F, Wei Y, Zhang J, et al. Transcriptomics analysis investigates sesquiterpenoids accumulation pattern in different tissues of Atractylodes lancea (Thunb.) DC. plantlet. Plant Cell Tiss Organ Cult 2017; 130:73-90.
41 Xing X, Chen S, Li L, et al. The active components of Fuzheng Huayu formula and their potential mechanism of action in inhibiting the hepatic stellate cells viability-a network pharmacology and transcriptomics approach. Front Pharmacol 2018; 9:525.
42 Li AP, He SS, Zhang WN, et al. Exploration the active compounds of Astragali Radix in treatment of adriamycin nephropathy by network pharmacology combined with transcriptomic approach. J Ethnopharmacol 2020; 258:112537.
43 He S, Li A, Zhang W, et al. An integrated transcriptomics and network pharmacology approach to exploring the mechanism of adriamycin-induced kidney injury. Chem Biol Interact 2020; 325:109096.
44 Zhou Y, Wu R, Cai FF, et al. Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFβ/Smad and Akt/FoxO3 signaling pathways based on network pharmacology and transcriptomic analysis. J Ethnopharmacol 2020; 2020:113021.
45 Li D, Liu D, Yue D, et al. Network pharmacology and RNA sequencing studies on triterpenoid saponins from Bupleurum chinense for the treatment of breast cancer. RSC Adv 2019; 9:41088-98.
46 Zhao P, Yang L, Li J, et al. Combining systems pharmacology, transcriptomics, proteomics, and metabolomics to dissect the therapeutic mechanism of Chinese herbal Bufei Jianpi formula for application to COPD. Int J Chron Obstruct Pulmon Dis 2016; 11:553-66.
47 Zhou B, Yuan Y, Zhang S, et al. Intestinal flora and disease mutually shape the regional immune system in the intestinal tract. Front Immunol 2020; 11:575.
48 Ma Y, Peng X, Yang J, et al. Impacts of functional oligosaccharide on intestinal immune modulation in immunosuppressive mice. Saudi J Biol Sci 2020; 27:233-41.
49 Szabo G. Gut-liver axis in alcoholic liver disease. Gastroenterology 2015; 148:30-6.
50 Krzyzaniak MJ, Peterson CY, Cheadle G, et al. Efferent vagal nerve stimulation attenuates acute lung injury following burn: the importance of the gut-lung axis. Surgery 2011; 150:379-89.
51 Wang Y, Meng SN, Zhang X, et al. Review of the intestinal flora alteration treated with Chinese medicine. Huan Qiu Zhong Yi Yao 2015; 8:620-23.
52 Zhang R, Zhu X, Bai H, et al. Network pharmacology databases for Traditional Chinese Medicine: review and assessment. Front Pharmacol 2019; 10:123.
53 Zhang Q, Yu K, Li S, et al. gutMEGA: a database of the human gut MEtaGenome Atlas. Brief Bioinform 2020; bbaa082.
54 Wu S, Sun C, Li Y, et al. GMrepo: a database of curated and consistently annotated human gut metagenomes. Nucleic Acids Res 2020; 48:D545-53.
55 Wang W, Xiao Y, Wang X, et al. Disordered gut microbiota in children who have chronic pancreatitis and different functional gene mutations. Clin Transl Gastroenterol 2020; 11:e00150.
56 Gao K, Yang R, Zhang J, et al. Effects of Qijian mixture on type 2 diabetes assessed by metabonomics, gut microbiota and network pharmacology. Pharmacol Res 2018; 130:93-109.
57 Ding Z, Zhong R, Yang Y, et al. Systems pharmacology reveals the mechanism of activity of Ge-Gen-Qin-Lian decoction against LPS-induced acute lung injury: a novel strategy for exploring active components and effective mechanism of TCM formulae. Pharmacol Res 2020; 156:104759.
58 Banerjee S, Bhattacharjee P, Kar A, et al. LC-MS/MS analysis and network pharmacology of Trigonella foenum-graecum-a plant from Ayurveda against hyperlipidemia and hyperglycemia with combination synergy. Phytomedicine 2019; 60:152944.
59 Liang X, Liu CS, Xia T, et al. Identification of active compounds of Mahuang Fuzi Xixin decoction and their mechanisms of action by LC-MS/MS and network pharmacology. Evid Based Complement Alternat Med. 2020; 2020:3812180.
60 Liang Z, Gu Y, Duan X, et al. Design of multichannel functional near-infrared spectroscopy system with application to propofol and sevoflurane anesthesia monitoring. Neurophotonics 2016; 3:045001.
61 Liu W, Chen XH, Ge YY, et al. Network pharmacology strategy for revealing the pharmacological mechanism of pharmacokinetic target components of San-Ye-Tang-Zhi-Qing formula for the treatment of type 2 diabetes mellitus. J Ethnopharmacol 2020; 113044:1-42.
62 Zhang C, Liu C, Qu Y, et al. LC-MS-based qualitative analysis and pharmacokinetic integration network pharmacology strategy reveals the mechanism of Phlomis brevidentata H.W.Li treatment of pneumonia. ACS Omega 2021; 6:4495-505.
63 Mahomoodally MF, Picot-Allain MCN, Zengin G, et al. Phytochemical analysis, network pharmacology and in silico investigations on anacamptis pyramidalis tuber extracts. Molecules 2020; 25:2422.
64 Shawky E. Prediction of potential cancer-related molecular targets of North African plants constituents using network pharmacology-based analysis. J Ethnopharmacol 2019; 238:111826.
65 Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017; 7:42717.
66 Wishart D, Knox C, Guo A, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 2006; 34:668-72.
67 Tao W, Li B, Gao S, et al. CancerHSP: anticancer herbs database of systems pharmacology. Sci Rep 2015; 5:11481.
68 Davies M, Nowotka M, Papadatos G, et al. ChEMBL web services: streamlining access to drug discovery data and utilities. Nucleic Acids Res 2015; 43:612-20.
69 Pence HE, Williams A. ChemSpider: an online chemical information resource. J Chem Educ 2010; 87:1123-4.
70 Xu HY, Zhang YQ, Liu ZM, et al. ETCM: an encyclopaedia of Traditional Chinese Medicine. Nucleic Acids Res 2019; 47:976-82.
71 Xiong GL, Wu ZX, Yi JC, et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res 2021; 49:5-14.
72 Chen XY, Gou SH, Shi ZQ, et al. Spectrum-effect relationship between HPLC fingerprints and bioactive components of Radix Hedysari on increasing the peak bone mass of rat. J Pharm Anal 2019; 9:266-73.
73 Chen Y, Pan G, Xu W, et al. Spectrum-effect relationship study between HPLC fingerprints and antioxidant activity of Sabia parviflora. J Chromatogr B Analyt Technol Biomed Life Sci 2020; 1140:121970.
74 Zhu CS, Lin ZJ, Xiao ML, et al. The spectrum-effect relationship-a rational approach to screening effective compounds, reflecting the internal quality of Chinese herbal medicine. Chin J Nat Med 2016; 14:177-84.
75 Zhao Y, Xie Q, He L, et al. Comparsion analysis of data mining models applied to clinical research in Traditional Chinese Medicine. J Tradit Chin Med 2014; 34:627-34.
76 Li K, Li J, Su J, et al. Identification of quality markers of Yuanhu Zhitong tablets based on integrative pharmacology and data mining. Phytomedicine 2018; 44:212-9.
77 Sun JH, Sun F, Yan B, et al. Data mining and systematic pharmacology to reveal the mechanisms of Traditional Chinese Medicine in mycoplasma pneumoniae pneumonia treatment. Biomed Pharmacother 2020; 125:109900.
78 Sun W, Cai Z, Li Y, et al. Data processing and text mining technologies on electronic medical records: a review. J Healthc Eng 2018; 2018:4302425.
79 Guo J, Shang E, Zhao J, et al. Data mining and frequency analysis for licorice as a "Two-Face" herb in Chinese formulae based on Chinese formulae database. Phytomedicine 2014; 21:1281-6.
80 Zheng W, Wu J, Gu J, et al. Modular characteristics and mechanism of action of herbs for endometriosis treatment in Chinese medicine: a data mining and network pharmacology-based identification. Front Pharmacol 2020; 11:147.
81 Ren L, Zheng X, Liu J, et al. Network pharmacology study of traditional Chinese medicines for stroke treatment and effective constituents screening. J Ethnopharmacol 2019; 242:112044.
82 Chen SJ. Drug-target networks for Tanshinone IIA identified by data mining. Chin J Nat Med 2015; 13:751-59.
83 Yang LN, Wu ZL, Yang ZJ, et al. Exploring mechanism of key Chinese herbal medicine on breast cancer by data mining and network pharmacology methods. Chin J Integr Med 2020; 27:919-26.
84 Zheng J, Wu M, Wang H, et al. Network pharmacology to unveil the biological basis of health-strengthening herbal medicine in cancer treatment. Cancers (Basel) 2018; 10:461.
85 Liu X, Lu P, Zuo XH, et al. Prediction of network drug target based on improved model of bipartite graph valuation. Zhong Guo Zhong Yao Za Zhi 2012; 37:125-29.
86 Zuo H, Zhang Q, Su S, et al. A network pharmacology-based approach to analyse potential targets of traditional herbal formulas: an example of Yu Ping Feng decoction. Sci Rep 2018; 8:11418.
87 Blondel V, Guillaume JL, Lambiotte R, et al. Fast unfolding of communities in large networks. J Stat Mech-theory E 2008; 2008:1-12.
88 Lambiotte R, Delvenne JC, Barahona M. Laplacian dynamics and multiscale modular structure in networks. IEEE Trans Netw Sci Eng 2008; 1:76-90.
89 Fang J, Cai C, Chai Y, et al. Quantitative and systems pharmacology 4. network-based analysis of drug pleiotropy on coronary artery disease. Eur J Med Chem 2019; 161:192-204.
90 Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser C Appl Stat 1995; 57:289-300.
91 Hu CJ, He J, Li GZ, et al. Analyzing hedyotis diffusa mechanisms of action from the genomics perspective. Comput Methods Programs Biomed 2019; 174:1-8.
92 Vanunu O, Magger O, Ruppin E., et al. Associating genes and protein complexes with disease via network propagation. PLoS Comput Biol 2010; 6:e1000641.
93 Shi YX, Lin XF, Qiong YU, et al. Clinical efficacy and safety evaluation of TCM treatment for obesity caused by psychoactive drugs. Zhong Hua Zhong Yi Yao Xue Kan 2016; 34:1268-70.
94 Arlt VM, Stiborova M, Schmeiser HH. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 2022; 17:265-77.
95 Chen M, Su M, Zhao L, et al. Metabonomic study of aristolochic acid-induced nephrotoxicity in rats. J Proteome Res 2006; 5:995-1002.
96 Balkrishna A, Manikyam HK, Sharma VK, et al. Safety evaluation of Picrorhiza kurroa Rhizome extract by bacterial reverse mutation test. Adv Stud Biol. 2016; 8:127-40.
97 Park H, Hwang YH, Ma JY. Single, repeated dose toxicity and genotoxicity assessment of herb formula KIOM2012H. Integr Med Res. 2017; 6:361-71.
98 Fan XH. Network toxicology and its application to Traditional Chinese Medicine. Zhong Guo Zhong Yao Za Zhi 2011; 36:2920-2.
99 Liu C, Zhang C, Wang W, et al. Integrated metabolomics and network toxicology to reveal molecular mechanism of celastrol induced cardiotoxicity. Toxicol Appl Pharmacol 2019; 383:114785.
100 Wang SF, Liu KC, Wang XM, et al. Preliminary study on cardiotoxicity of celastrol to zebrafish embryo. Zhong Guo Yao Li Xue Tong Bao 2009; 25:634-6.
101 Hou L, Wang L, Liu RP, et al. Study on basis of liver toxicity of decoction Bupleurum chinense based on integrated model of spectrum toxicity relationship and liver toxicity network. Zhong Cao Yao 2020; 51:2798-806.
102 Li YX, Peng C. The application of "Efficacy components group" in toxicity/effect material basis of Traditional Chinese Medicine. Zhong Yao Yu Lin Chuang 2018; 9:53-65.
103 Rugard M, Coumoul X, Carvaillo JC, et al. Deciphering adverse outcome pathway network linked to bisphenol F using text mining and systems toxicology approaches. Toxicol Sci 2020; 173:32-40.
Options
Outlines

/

〈 〉